Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

SLU-PP-332 vs. Similar Peptides: Side Effect Comparison

When comparing SLU-PP-332 to similar research peptides, such as GW501516, which also targets PPARδ, the side effect profiles can vary. For instance, GW501516 has been associated with more pronounced cardiovascular risks in animal studies. Here is a brief compa

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • When comparing SLU-PP-332 to similar research peptides, such as GW501516, which also targets PPARδ, the side effect profiles can vary. For instance, GW501516 has been associated with more pronounced cardiovascular risks in animal studies. Here is a brief comparison:
  • SLU-PP-332
  • Gastrointestinal discomfort, fatigue
  • Metabolic disturbances
  • GW501516
  • Nausea, fatigue
  • Cardiovascular events